Financial Disclosure

CAI Commits Up to $268M to SMT Energy's Battery Storage Platform

New York – September 25, 2026 -- Climate Adaptive Infrastructure (CAI) has agreed to invest up to $268 million at the parent-company level into SMT Energy, a developer, owner and operator of battery energy storage systems, on top of $32 million CAI had already deployed into SMT assets.

CAI structures a parent-level equity partnership to fund SMT's U.S. storage buildout

The capital commitment, combined with tax equity and project-level debt, will finance the development, construction and operation of SMT Energy's battery storage portfolio across the United States. The platform spans distributed-generation and utility-scale battery storage as well as powered land projects aimed at reinforcing grid reliability.

Global Fight League Sells First Franchise for Seven Figures

Las Vegas – September 25, 2026 -- Global Fight League (OTC: GFLE) has signed a seven-figure binding Letter of Intent with investor Ryan Brockbank for the rights to own and operate the league's first independently owned franchise, marking its inaugural third-party ownership deal.

GFL secures non-refundable payment to fund Argentina proof-of-concept event

GFL has received and deposited a non-refundable initial payment toward the seven-figure purchase price, with the remaining balance due in 2027. The capital will help finance an international proof-of-concept event in Argentina during the fourth quarter of 2026, with further details expected in the coming week, as well as preparations for the league's first full season of competition in 2027.

Aqua Medical Closes Series B to Fund US Trial for Diabetes Device

Pleasanton, Calif. – – September 25, 2026 -- Aqua Medical, Inc. has closed a Series B financing round led by Nashville-based Relevance Ventures, with proceeds earmarked to complete its ongoing U.S. RESTORE-1 pilot study and prepare for a planned U.S. pivotal trial of its investigational diabetes procedure.

Series B capital targets completion of RESTORE-1 pilot and pivotal trial launch

The financing will fund the remaining stages of the RESTORE-1 pilot study, which is evaluating Aqua Medical's Proximal Intestinal Mucosal Ablation (PIMA) procedure for Type 2 diabetes under an FDA-approved Investigational Device Exemption. The company said the round will also support operational preparations, including patient recruitment infrastructure, for a larger planned pivotal trial subject to regulatory authorization.

OceanaGold Eyes 1.2 Mtpa Waihi Expansion on High-Grade Drill Hits

Vancouver – September 25, 2026 -- OceanaGold Corporation (TSX: OGC) (NYSE: OGC) reported new drill results from its Wharekirauponga project in New Zealand, including an intercept of 6.3 metres grading 97.2 g/t gold, among the highest-grade results returned to date at the deposit.

Sixteen new holes confirm high-grade continuity at Wharekirauponga's East Graben Vein

The 16 holes, completed since an September 25, 2026 update, targeted the East Graben (EG) Vein and adjacent Hanging Wall (HW) structures. Results included 8.5 m at 41.5 g/t gold from 399.0 metres depth, 9.6 m at 18.5 g/t gold from 401.0 metres, and 6.6 m at 24.0 g/t gold including a 1.2 m section at 107.7 g/t gold. The company said the intercepts extend the southern high-grade zone up-dip and along strike, an area currently outside reported reserves.

Basecamp Research Raises $140M to Advance AI-Designed Cell Therapies

London and Boston – September 25, 2026 -- Basecamp Research has closed a $140 million oversubscribed Series C financing to train new EDEN foundation models and push a pipeline of AI-designed therapeutics toward clinical development.

S32 leads a syndicate spanning NVIDIA, Anthropic-adjacent backers and sovereign funds

The round was led by S32, with participation from NVIDIA, Menlo Ventures' Anthology Fund, Catalio Capital Management, European Tech Collective, Firebrand River Capital, Inception Fund, King Philanthropies, NATO Innovation Fund, PostScriptum, Redalpine, The Rockefeller Foundation, Singular, Sovereign AI and True Ventures. Andy Conrad, General Partner at S32 and former CEO of Google's Verily, joins Basecamp's Board of Directors.

Cloopen Shareholders Approve Go-Private Merger With 99.98% Vote

Beijing – September 25, 2026 -- Cloopen Group Holding Limited (OTC: RAASY) shareholders approved a merger agreement that will take the Chinese cloud communications provider private, with approximately 99.98% of votes cast at an extraordinary general meeting backing the deal.

Shareholders clear merger with SpringX Holdings and related entities

The Merger Agreement involves SpringX Holdings Limited as Parent, AutumnX Holdings Limited as HoldCo, and SummerX Holdings Limited as Merger Sub, all exempted companies incorporated in the Cayman Islands. Under the structure, Merger Sub will merge into Cloopen pursuant to Part 16 of the Cayman Islands Companies Act, with Cloopen surviving as a wholly-owned subsidiary of HoldCo.

MIAX FCM Dorman Trading Joins OCC, Adds $40M in Capital

Miami – – September 25, 2026 -- Miami International Holdings, Inc. (MIAX) announced that its futures commission merchant, Dorman Trading, has become a clearing member of The Options Clearing Corporation (OCC), the world's largest equity derivatives clearing organization.

MIAX injects $40 million into its FCM, lifting adjusted net capital to $68 million

The capital increase, effective as of September 25, 2026, raises Dorman Trading's adjusted net capital to approximately $68 million. MIAX said the additional funding is intended to accelerate the FCM's growth strategy and expand its capacity to serve a broader client base.

US Functional Unemployment Eases to 24.3% in August, LISEP Says

Washington, D.C. – September 25, 2026 -- The Ludwig Institute for Shared Economic Prosperity (LISEP) reported that its True Rate of Unemployment (TRU) fell 0.6 percentage points in August to 24.3%, down from 24.9% in July, partially reversing a four-month climb that began in March. The August reading still sits above January's 23.9%, following a 1.3-point rise between March and July. By contrast, the U.S. Bureau of Labor Statistics headline unemployment rate held steady at 4.1% in August.

TRU Out of Population measure drops to 53.2%, tracking labor force participation gains

LISEP's TRU Out of the Population (TRU OOP)—which captures the share of the working-age population not functionally employed, including those who have exited the labor force—declined 0.6 percentage points to 53.2%. LISEP said the move aligns with the BLS-reported improvement in labor force participation.

Down Payments Fall to Five-Year Q2 Low as Rates Drive Monthly Costs Up 74%

Austin, Texas – September 25, 2026 -- The typical U.S. down payment fell to $27,100 in the second quarter, the lowest second-quarter level since 2021, even as higher mortgage rates pushed estimated monthly payments up 74% over five years to $2,376, according to Realtor.com's second-quarter Down Payment Report.

Down payments drop 9.2% year over year despite seasonal rebound

The median down payment rose seasonally to $27,100, or 13.7% of purchase price, in the second quarter from $25,000, or 12.9%, in the first quarter. That still marked a decline of 9.2% in dollar terms and 0.6 percentage points as a share of price versus the $29,900, or 14.3%, recorded a year earlier. The rebound extended into July, when the typical down payment hit an annual high of $28,800, or 14.0%, still 7.5% below year-ago levels.

Daewoong Completes 104-Patient Phase 2 Enrollment for IPF Drug Bersiporocin

Barcelona – September 24, 2026 -- Daewoong Pharmaceutical has completed enrollment of 104 idiopathic pulmonary fibrosis (IPF) patients in its global Phase 2 trial of Bersiporocin (DWN12088), with top-line results now expected in the first half of 2027.

Trial spans South Korea and the US with balanced enrollment

Of the 104 patients, 55 (52.9%) were enrolled in South Korea and 49 (47.1%) in the United States. The company presented full baseline patient characteristics at the European Respiratory Society (ERS) Congress 2026 in Barcelona on September 6, following interim data shared earlier at KATRDIC 2025.